Corporate insider profile
Robin Shane Readnour Insider Trades
Latest reported as Director of AN2 Therapeutics, Inc. (ANTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$316,700.52
- Latest transaction
- Sep 9, 2026
Affiliated corporations
Reported company relationships
Transaction history
